A U.S. based generic pharmaceutical company was required to file original ANDA applications to the USFDA while tracking the versions of the changed documents and replacing them in the eCTD format. The client was facing challenges in terms of the volume of documents to be addressed in the given timeline.

Read the case study to know how Freyr helped managed to handle the large volume of documents compliantly.